Research & Development



  到了那時候,百姓不僅僅是在為國朝出力,也是在為自己的好日子不失去出力。   如此天下,誰能動搖分毫?”每日更新在线观看av   “啟稟君侯,太僕寺門下養馬中郎金日求見。”不卡的无码高清的av   劉徹冷哼一聲道︰“就在雲氏的後山里……當年他一心要這片土地的時候,朕就派人查過……哼哼哼……居然是始皇陵!   一聲驚呼從包房方向傳來,隨即一個憤怒的聲音大吼道︰“金日,你在這里干什麼!”超碰在线   他覺得自己的喉嚨感覺不到冰冷……

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo